Findings

What do systematic reviews say?

9 questions · 9 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 33.3%GRADE not reported 0 · 0%Very low 6 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Cell salvage vs no cell salvage

Mortality (up to 90 days) · cardiovascular (vascular) surgeries

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
1.19 [0.39, 3.65]
6 studies · 384 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) · cardiovascular (no bypass) surgeries

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
0.13 [0.01, 2.07]
4 studies · 209 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) · cardiovascular (with bypass) surgeries

It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
RR 0.86 [0.5, 1.48]
21 studies · 2491 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) · cancer surgery

It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
RR 0.56 [0.11, 2.8]
2 studies · 79 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) · orthopaedic (hip)

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
0.46 [0.06, 3.33]
4 studies · 651 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) · orthopaedic (mixed)

It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
RD 0
1 study · 69 participants
Very low

Cell salvage vs no cell salvage

Mortality (up to 90 days) ‐ not reported · obstetric surgeries

The review found no eligible studies for this question.

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cell salvage vs no cell salvage

Mortality (up to 90 days) ‐ not reported · orthopaedic (knee)

The review found no eligible studies for this question.

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cell salvage vs no cell salvage

Mortality (up to 90 days) ‐ not reported · orthopaedic (spinal)

The review found no eligible studies for this question.

1 finding from 1 review

Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found